Skip to main content
. 2021 Oct 13;101(3):270–277. doi: 10.1177/00220345211037220

Table 1.

Baseline Characteristics for the Dementia and Alzheimer’s Disease Cohorts After Propensity Score Matching.

Dementia, n (%) Alzheimer’s Disease, n (%)
Control (n = 8,640) Case (n = 8,640) ASD Control (n = 606) Case (n = 606) ASD
Sex 0.0071 0.0232
Female 4,434 (51.32) 4,465 (51.68) 340 (56.11) 333 (54.95)
Male 4,206 (48.68) 4,175 (48.32) 266 (43.89) 273 (45.05)
Age, y 0.0651 0.0000
≤60 1,913 (22.14) 2,065 (23.90) 49 (8.09) 46 (7.59)
61 to 70 1,591 (18.41) 1,629 (18.85) 99 (16.34) 95 (15.68)
71 to 80 3,018 (34.93) 2,930 (33.91) 247 (40.76) 247 (40.76)
≥81 2,118 (24.51) 2,016 (23.33) 211 (34.82) 218 (35.97)
Comorbidities
Diabetes mellitus 1,840 (21.30) 1,800 (20.83) 0.0113 133 (21.95) 137 (22.61) 0.0159
Stroke 624 (7.22) 620 (7.18) 0.0017 52 (8.58) 53 (8.75) 0.0059
Hypertension 4,730 (54.75) 4,584 (53.06) 0.0339 339 (55.94) 350 (57.76) 0.0367
TBI 254 (2.94) 260 (3.01) 0.0040 23 (3.80) 27 (4.46) 0.0332
COPD 1,378 (15.95) 1,366 (15.81) 0.0038 94 (15.51) 102 (16.83) 0.0359
CVD 1,978 (22.89) 1,989 (23.02) 0.0030 132 (21.78) 138 (22.77) 0.0238
Hyperlipidemia 1,957 (22.65) 1,896 (21.94) 0.0169 128 (21.21) 136 (22.44) 0.0320

Values are presented as No. (%) unless noted otherwise.

ASD, absolute standardized difference; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular diseases; TBI, traumatic brain injury.